🔖 What This Document Is

This is a 6-K filing from Curaleaf Holdings, a Canadian-listed cannabis company. It's a "current report" used to announce important news to investors. This specific filing announces that the company's Chief Legal Officer has set up a pre-arranged plan to sell some of his company shares in the future. It’s a routine disclosure about executive compensation and trading plans.

🏢 What The Company Does

👉 In simple terms, Curaleaf is a major "pot" company. They grow, process, and sell cannabis products for both medical and recreational adult-use markets. Think of them as a large, multinational brand in the cannabis industry, operating under names like "Curaleaf" and "Select." They have operations across the U.S., Europe, Canada, and Australasia.

🔍 The Details: Peter Clateman's ASDP

The core of this announcement is about Peter Clateman, the company's Chief Legal Officer. He has extended an Automatic Securities Disposition Plan (ASDP).

• What it is: An ASDP is like a pre-set "autopilot" sale plan for an executive's shares. It's set up under strict rules to ensure sales are orderly and not based on inside information.
• The Goal: To sell enough shares to cover tax bills that will come due when his vested stock options expire in July 2027.
• How it works: An independent broker will handle the sales at prevailing market prices, following specific rules on timing and volume.

📅 Key Dates & Timeline

The plan became effective March 31, 2026. Sales under this plan are scheduled to begin on or about July 1, 2026 and will continue over a six-month period.

⚖️ Why This Matters For Investors

This is NOT a red flag or a sign of trouble. Here’s why: 👍 It's Pre-Planned: The plan was set up before a company "blackout period" began, meaning Mr. Clateman isn't reacting to secret, upcoming news. 👍 It's Routine & Transparent: These plans are common for executives. The sales are fully disclosed, and the plan has strict limits that are hard to change. ⚠️ Potential Perception Risk: Even though it's routine, any insider selling can sometimes make other investors nervous. However, the stated purpose (tax coverage) is a legitimate and typical reason.

📦 Company Context & Stock Info

Curaleaf is listed on the Toronto Stock Exchange (CURA) and trades on the U.S. OTCQX market (CURLF). This filing relates to the subordinate voting shares that trade on both exchanges.

🧠 The Analogy

Imagine an athlete who gets a large bonus in team stock but is told, "This stock vests in two years, and when it does, you'll owe a big tax bill." To prepare, the athlete sets up an automatic plan with their financial advisor now: "In two years, automatically sell just enough stock each month to pay the IRS, no matter if the team is winning or losing." That’s exactly what Peter Clateman has done.

📇 Key Contacts & People

• Peter Clateman: Chief Legal Officer
• Camilo Lyon: Chief Investment Officer (Investor Contact)
• Investor Email: [email protected]
• Media Contact: MATTIO Communications ([email protected])

🧩 Final Takeaway

This filing is a standard administrative announcement about a top executive's pre-arranged plan to sell shares in the future primarily to cover tax obligations. It’s a normal part of executive compensation management and not a signal about the company's near-term outlook.